German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)

Adult Acute Lymphocytic Leukemia Clinical Trial

Official title:
Multicenter Trial for Treatment of Acute Lymphoblastic Leukemia in Adults (05/93)

Status Completed

Clinical Trial Summary

The study evaluates the efficacy and tolerability of a risk- and subtype-adapted chemotherapy over one year, followed by randomized either intensified or conventional maintenance therapy. It includes a distinct protocol for the subgroup 'mature B-ALL',

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Adult Acute Lymphocytic Leukemia
Leukemia
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trial Details

NCT number	NCT00199069
Study type	Interventional
Source	Goethe University
Contact
Status	Completed
Phase	Phase 4
Start date	April 1993
Completion date	May 2001

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00199056` - German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)	Phase 4
Completed	`NCT00199043` - Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma	Phase 3
Completed	`NCT00198978` - German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	Phase 4
Completed	`NCT00199095` - Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia	Phase 4
Completed	`NCT00199004` - Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab	Phase 4
Completed	`NCT00199108` - Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt	Phase 2/Phase 3
Completed	`NCT00198991` - German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)	Phase 4